HF Acquisition Co LLC: Drug Recall

Recall #D-0870-2023 · 06/06/2023

Class III: Low Risk

Recall Details

Recall Number: D-0870-2023
Classification: Class III
Product Type: Drug
Recalling Firm: HF Acquisition Co LLC
Status: Terminated
Date Initiated: 06/06/2023
Location: Mukilteo, WA, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 9 boxes of 25 vials

Reason for Recall

Labeling: Label Mix-up

Product Description

GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3

Distribution Pattern

Distributed in TX, AZ and CA only

Other Recalls by HF Acquisition Co LLC

Class II: Risk 12/11/2024

Spore test strip monitoring system, designed for routine monitoring of sterilization processes, may have a printing error on the return envelope that may cause spore test results to be reported to the incorrect customer's account.

View all recalls by HF Acquisition Co LLC →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.